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Previously, the unusual ion composition [M 1 Fe 2 5H]22 had been proposed as the major
species observed when a g-carboxy glutamate-containing glyco-peptide was analyzed with
electrospray ionization in the negative ionization mode. The sequence assignment of this
highly post-translationally modified peptide was based on the mass analysis using a
quadrupole ion trap together with information from both Edman and DNA sequencing.
Because there was little precedent for the loss of five protons from a ferric cationized peptide,
we utilized Fourier transform mass spectrometry accurate mass and tandem mass spectrom-
etry analyses to verify the peptide ion composition. (J Am Soc Mass Spectrom 2000, 11,
83–87) © 2000 American Society for Mass Spectrometry
The resolution and mass precision afforded byFourier transform mass spectrometry (FTMS) [1]for ions formed by electrospray ionization (ESI)
set this method of mass analysis in a separate class in
terms of the accuracy of measurement in both mass
spectrometry and MS/MS type experiments. Previ-
ously, we have analyzed a g-carboxy glutamate-con-
taining glyco-peptide, tx5a, with electrospray ionization
on a quadrupole ion trap instrument. The proposed
sequence of peptide tx5a was H-Gla-Cys-Cys-Gla-Asp-
Gly-Brp-Cys-Cys-Thr*-Ala-Ala-Hyp-OH (Gla 5 g-car-
boxy glutamate, Cys 5 pyridyl ethyl cysteine, Brp 5
bromotryptophan, Thr* 5 Hex-HexNAc-threonine, and
Hyp 5 hydroxyproline [2]. [Note added in press: The
peptide tx5a belongs to a new family of Conus peptides
and was named according to a proposed general no-
menclature scheme (see [2]); tx5a has also been inde-
pendently characterized (as e-TxIX see: Rigby, A. C.;
Lucas-Meunier, E.; Kalume, D. E.; Czerwiec, E.; Hambe,
B.; Dahlqvist, I.; Fossier, P.; Baux, G.; Roepstorff, P.;
Baleja, J. D.; Furie, B. C.; Furie, B.; Stenflo, J. Proc. Natl.
Acad. Sci. USA 1999, 96, 5758–5763.] This peptide, which
had been isolated from Conus textile venom, was pro-
posed to contain nine modified amino acids in a 13
amino acid sequence [2]. Six different types of post-
translational modifications, including g-carboxylation
of glutamate [3, 4], bromination of a tryptophan residue
[5, 6], and O-linked glycosylation [7, 8] were found to be
present in the peptide. It was proposed that the reduced
and alkylated form of the peptide formed the unusual
ion composition [M 1 Fe 2 5H]22 as the major species
in the electrospray mass spectrum measured in the
negative ionization mode. This ion composition was
based on mass spectrometry data and information
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gleaned by combining the chemical sequence data to-
gether with the isolation of a cDNA clone encoding for
this peptide.
A number of limitations in the initial analysis led us to
undertake a more detailed study utilizing the resolution,
sensitivity, and mass precision of FTMS. A major question
revolved around the cDNA clone which predicted a 15
amino acid peptide (H-Glu-Cys-Cys-Glu-Asp-Gly-Trp-
Cys-Cys-Thr-Ala-Ala-Pro-Leu-Thr-NH2 [2]). In addition,
the evidence for the presence of several modifications
such as the two g-carboxy glutamate, bromotrypto-
phan, and hexose-N-acetyl hexosamine-threonine resi-
dues was based on the cDNA clone sequence and the
absence of PTH derivatives for the residues predicted
by the clone using standard Edman sequence analysis
(e.g., the predicted residue in position 10 is Thr based
on the cDNA clone, the absence of a PTH signal for Thr
in the chemical sequence analysis suggests a modified
Thr residue). These results were supported by mass
spectrometry and MS/MS data measured with ESI on a
quadrupole ion trap with three reservations. The first
reservation was that the observed intact mass which
supported the presence of these modifications was
based on the unusual [M 1 Fe 2 5H]22 composition.
The second reservation was that the MS/MS spectrum
did not include fragments that would typically be
observed from a Hex-HexNAc-containing O-linked gly-
copeptide. Third, losses were observed corresponding
to decarboxylation of both of the proposed g-carboxy
glutamate residues, which presumably coordinated to
the ferric cation, without loss of the cation.
Two general lines of reasoning could explain the
conflicting results. First, the two amino acids predicted
by the cDNA clone were present but not observed in the
chemical sequence analysis and that one or more of the
modifications and the ion composition were incorrectly
assigned. Second, some additional C-terminal process-
ing events had occurred to remove the two amino acids
predicted by the cDNA clone and the ion composition
and the MS/MS fragmentation patterns were correct
but unusual. Because we were unaware of any prece-
dent for the loss of five protons from a ferric cationized
peptide ion we used FTMS MS/MS and accurate mass
analyses to verify the proposed intact ion composition
and the fragmentation pattern.
Experimental
Reduction and Alkylation of the tx5a Peptide
tx5a was isolated and purified as described elsewhere
[2]. The reduced peptide [using 50 mM tris(2-carboxy-
ethyl)phosphine] was isolated and directly alkylated
with 4-vinyl pyridine in pyridine (1:1000) and repuri-
fied using reverse phase high performance liquid chro-
matography (Vydak C18 2.1 3 250 mm 5 mm, 300 Å
column) A buffer 0.055% aqueous trifluoroacetic acid, B
buffer 0.05% aqueous trifluoroacetic acid in 90% aceto-
nitrile. Based on the proposed tx5a sequence the ele-
mental composition is C98H128O36N19S4Br (2353.683557
Da). Iron has four major isotopes, where 54Fe has 6.3%
relative abundance compared with the most abundant
56Fe isotope. When a molecule is cationized with Fe, we
use the (A 1 2) isotopomer for comparison with the
observed species.
Mass Spectrometry
All mass spectrometry experiments were carried out on
a Fourier transform mass spectrometer (Bruker Dalton-
ics) equipped with an actively shielded 4.7 tesla magnet
and an ESI source (Analytica of Branford). The peptide
(approximately 1 pmol/mL) was diluted in methanol
containing 3% acetic acid (1:1) and infused in a syringe
pump-assisted nanospray source (New Objective) in the
positive ionization mode at 150 nL/min or a syringe
pump-driven microspray source with nebulizer gas in
the negative ionization mode at 500 nL/min. In the
mass spectra, internal calibration was performed using
three peptide calibrant ions, where the observed cali-
bration fit was within 3 ppm (calibrants were at back-
ground levels after flushing of the electrospray source
for .1 h). In all mass spectra, between 16 to 25 scans
were averaged, each consisting of a 512K data set.
For MS/MS experiments, argon was pulsed into the
analyzer region to 1.5 3 1026 mbar, followed by a SORI
[9] rf-excitation pulse (500 Hz off-resonance, duration of
250 m, 2.5–3.5 Vpp). A 6 s delay for pumpdown and
dissociation was followed by detection of the fragment
ions. In all MS/MS spectra, between 25 to 50 scans were
averaged, each consisting of a 512K data set.
Elemental Composition Search
Based on the original reduction and alkylation experi-
ments and the resulting mass shift of 424 Da, we could
conclude that tx5a contained four cysteine residues [2]
and therefore four sulfur atoms. Similarly, the biochem-
ical data and the close correspondence between the
observed and calculated isotope distribution (see Figure
1A, B) indicated one bromine and one iron atom. Based
on the presence of two g-carboxy glutamate residues
(verified by the MS/MS spectrum), one aspartic acid
residue and a threonine hexose residue in a 13 amino
acid peptide, 5 residues with additional nitrogen atoms
(4 pyridyl ethyl cysteines and bromotryptophan) we
obtained a minimum elemental composition of
C89H115N17O29S4Br1Fe1. Finally, the odd molecule mass
indicates an odd number of nitrogen atoms in the
molecule. The elemental composition search was car-
ried out with the XMASS program (Bruker Daltonics,
Billerica, MA).
Results and Discussion
FTMS accurate mass analysis of the [M 1 Fe]31 cluster
of isotopomers indicated the (A 1 2) isotope was ob-
served at m/z 803.20276 [and therefore an observed
84 CRAIG ET AL. J Am Soc Mass Spectrom 2000, 11, 83–87
mass (M) of 2353.674888 Da]. This compared favorably
(error of ,3.7 ppm) with the calculated mass for
[C98H128O36N19S4BrFe]
31 (m/z 803.2056178). In addition,
the observed isotope distribution for the [M 1 Fe]31
cluster of isotopomers shown in Figure 1A closely
matched the calculated isotopomer distribution (Figure
1B). We noted that we observed very weak species
corresponding with the monoisotopic species (i.e., the A
isotopomer incorporating 54Fe) and the (A 1 1) isoto-
pomer at masses 2/3 and 1/3 Da, respectively, below
the mass of the (A 1 2) isotopomer. A doubly charged
impurity and the corresponding (A 1 1) isotopomer of
this impurity are labeled with an asterisk in Figure 1A.
In Figure 2, the FTMS spectrum measured in the
negative ionization mode shows the [M 1 Fe 2 5H]22
cluster of isotopomers sandwiched between two impu-
rities; a dominant singly charged impurity at m/z ’
1200, the corresponding (A 1 1) isotopomer and a
separate impurity at m/z ’ 1204 of similar intensity to
[M 1 Fe 2 5H]22 (each marked with asterisks). Accu-
rate mass analysis of the (A 1 2) isotope of the [M 1
Fe 2 5H]22 indicated an observed m/z 1202.285819 (and
therefore M 2353.67489 Da). This compared favorably
(error of ,3.8 ppm) with the calculated mass for
[C98H123O36N19S4BrFe]
22 (m/z 1202.2902356). We note a
good correlation between the observed and calculated
[M 1 Fe 2 5H]22 isotope distribution (data not shown)
with the exception that the (A 1 2) isotope species of
the m/z ’ 1200 impurity contributes to the (A 1 3) of
the tx5a isotope distribution, disproportionately in-
creasing the (A 1 3) isotopomer intensity.
The MS/MS spectrum of the m/z 804, [M 1 Fe]31
cluster, is shown in Figure 3. We observed a number of
facile neutral losses from this parent generating triply
charged fragment ions, including loss of H2O/NH3,
CO2, H2O/NH3 1 CO2, 2CO2, H2O/NH3 1 2CO2
(shown in inset B), and hexose, hexose 1 H2O/NH3,
and hexose 1 H2O/NH3 1 CO2 (shown in inset A).
However, we did not observe any significant singly or
doubly charged fragment ions corresponding to loss of
small portions of the molecule (fragment ions are ob-
served below m/z 300 Da). This is seen as further
evidence for ferric cationization because lower charge
species (singly or doubly) would involve a complex
(presumably energetically unfavorable) process
whereby the iron atom is lost, whereas the peptide
retains a positive charge. The weak intensity of the
Figure 1. (A) Observed FTMS positive electrospray spectrum of
tx5a and (B) calculated isotopomer profile for the elemental
composition C98H123O36N19S4BrFe corresponding to [M 1 Fe]
31
[a doubly charged impurity and the corresponding (A 1 1) isoto-
pomer of this impurity are marked with asterisks].
Figure 2. Observed FTMS negative electrospray spectrum of tx5a
showing [M 1 Fe 2 5H]22 [a singly charged impurity at m/z ’
1200, the corresponding (A 1 1) isotopomer and a separate impu-
rity at m/z ’ 1204 are marked with asterisks].
Figure 3. MS/MS spectrum of m/z 804 precursor between 400
and 1200 Da, insets show expanded regions of (A) 720–760 and (B)
760–810 Da.
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species corresponding with the loss of hexose and the
absence of a species corresponding to loss of N-acetyl
hexosamine is in contrast with MS/MS spectra of other
O-linked Conus glyco-peptides containing N-acetyl hex-
osamine and terminal hexose residues [10, 11].
The mass spectrum verifies the presence of bromo-
tryptophan, the mass spectrum and the MS/MS spectra
verify the iron adduct, whereas the MS/MS spectrum is
consistent with the presence of two g-carboxy gluta-
mate residues. Therefore, with the exception of the
N-acetyl hexosamine moiety, the modifications not ob-
served by Edman sequencing have been verified as
present. We note that the mass difference between the
peptide with all of these modifications (i.e., except the
N-acetyl hexosamine) is less than the mass of the extra
residues (leucine and threonine) predicted by the cDNA
clone (214 Da; C10H18O3N2). We can therefore exclude
the line of reasoning that the residues predicted by the
cDNA clone were present in the peptide and not
observed by Edman sequencing. We suggest that the Fe
atom is able to stabilize the linkage between the threo-
nine residue and the glycan moiety thereby signifi-
cantly reducing the loss of hexose-N-acetyl hexosamine
and marginally reducing the extent of hexose loss in the
MS/MS spectra. In addition, the HexNAc residue to-
gether with the two remaining carboxylate groups
appears to be sufficient to retain the ferric coordinated
cation explaining the multiple loss of CO2 groups
without loss of the iron atom.
In general, 3–4 ppm mass accuracy for a molecule of
2400 Da is not sufficient for matching the calculated
mass of a particular elemental composition structure
with an observed mass. However, we note that by
significantly increasing the accuracy of mass measure-
ment compared with the quadrupole ion trap measure-
ment we have increased our confidence in an unusual
composition assignment.
In addition, this level of mass accuracy in combina-
tion with constraints based on biochemical information
can be used to limit the number of candidate elemental
composition structures, which match the observed
mass. In this instance a search with the constraints (see
Experimental section for minimum element composi-
tion) 89 , C , 130; 115 , H , 150; 17 , N , 30
where N is odd; 29 , O , 40; S 5 4; Br 5 and Fe 5 1
results in only 11 candidate structures where the error is
, 4 ppm (see Table 1). Of these 11 candidates, the
difference in the elemental composition of the candidate
structure and the minimum element composition (d)
results in only one feasible structure (10). The other
candidate structures, which are considered unfeasible,
constitute a modification with either too many hetero-
atoms (N or O) or two few H atoms for the number of
C atoms. In contrast, candidate 10 corresponds with the
elemental structure of an N-acetyl hexosamine unit, a
common structural motif previously observed in O-linked
glyco peptides and in Conus peptides specifically [10, 11].
Conclusion
The mass accuracy of the FTMS measurement, the close
fit between observed and calculated isotope distribu-
tions and the MS/MS data are used to verify the
presence of three post-translational modifications. In
combination with the available biochemical information
concerning the tx5a peptide, and based on a minimum
elemental formula of C89H115O30N18S4BrFe we observe
11 candidate elemental composition structures are
within a mass measurement error of , 4 ppm of the
observed mass. Of these candidates only one, corre-
sponding with N-acetyl hexosamine, represents a feasible
previously identified modification. The FTMS results con-
clusively assign the composition of the [M 1 Fe]31 and
[M 1 Fe 2 5H]22 species and thereby the structure of this
highly post-translationally modified peptide.
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TABLE 1. Elemental composition candidate structures and calculated m/z matching an observed m/z 803.20276 species where 89 ,
C , 130; 115 , 150; 17 , N , 30 where N is odd; 29 , O 40 ; S 5 4; Br 5 and Fe 5 and error , 4 ppm
No. 12C 1H 160 14N 32S 79Br 56Fe
m/z Error d d d d
(z 5 3) (e 2 6) 12C 1H 160 14N
1 100 124 33 21 4 1 1 803.2023191 0.5489 10 9 3 3
2 105 124 31 19 4 1 1 803.2036600 1.121 15 9 1 1
3 96 120 31 27 4 1 1 803.2014240 1.663 6 5 1 9
4 93 128 38 21 4 1 1 803.2042769 1.889 3 13 8 3
5 95 124 35 23 4 1 1 803.2009782 2.218 5 9 5 5
6 94 124 34 25 4 1 1 803.2047227 2.444 4 9 4 7
7 94 128 39 19 4 1 1 803.2005324 2.773 4 13 9 1
8 95 120 30 29 4 1 1 803.2051685 2.999 5 5 0 11
9 91 120 30 29 4 1 1 803.2000831 3.333 1 5 3 11
10 98 128 36 19 4 1 1 803.2056178 3.558 8 13 6 1
11 90 124 37 25 4 1 1 803.1996373 3.888 0 9 7 7
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